Related Articles
Downregulation of high mobility group protein box‑1 resensitizes ovarian cancer cells to carboplatin
Repression of Dicer is associated with invasive phenotype and chemoresistance in ovarian cancer
Inhibition of MCM2 enhances the sensitivity of ovarian cancer cell to carboplatin
Clinical significance and biological role of Wnt10a in ovarian cancer
Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis